Eskayef Pharmaceuticals Limited

Eskayef Pharmaceuticals Limited, a successor of world-renowned multinational pharma company, SmithKline & French (SK&F), USA was acquired by TRANSCOM in 1990 in the wake of the merger between SmithKline & French, USA and Beecham, UK. TRANSCOM is one of the leading and fastest growing business conglomerates in Bangladesh. Like TRANSCOM, not many industrial groups in Bangladesh can claim a history of continuous business pursuits stretching back over 100 years. Over the time, its early industrial ventures have moved over to businesses involved in high-tech manufacturing, international trading and distribution, forming strong ties with a host of blue chip multinational companies.

After the acquisition of SK&F by TRANSCOM, the new company was named – Eskayef Bangladesh Limited, which was renamed later as Eskayef Pharmaceuticals Limited. Eskayef has subsequently culminated to become one of the leading pharmaceutical companies of Bangladesh. Rapid business growth since its inception have propelled Eskayef to a position of eminence among the pharmaceutical companies operating in Bangladesh today.

Mission:

To manufacture & supply products with quality and excellency & to contribute to improve the population’s health & well-being.

Vision:

To lead the national pharmaceutical market, to be recognized as a multinational conglomerate from Bangladesh and stand out as a model of efficiency & trust to our collaborators, consumers, health care professionals & society.

Quality approach:

Eskayef believes that pharmaceutical business is built solely on the blocks of trust and it takes perseverance for a pharmaceutical business entity to earn the trust of the people. Many global best practices are being cultured in the everyday activities of Eskayef, which are contributing in a big way to shape up its future & earning people’s trust.

Business Philosophy:

Eskayef is a quality driven and scientific information based company. The EU GMP (European Union Good Manufacturing Practice), UK MHRA (Medicines and Healthcare Products Regulatory Agency of UK), TGA Australia (Therapeutic Goods Administration of Australia), UAE GMP (United Arab Emirates Good Manufacturing Practice) and VMD UK (Veterinary Medicines Directorate of UK) approved state-of-the-art pharmaceutical manufacturing facility has further reinforced high standards of quality, safety and efficacy of Eskayef products. The company is currently exporting medicines to many countries across four continents, including some highly regulated markets in Europe and Australia. Eskayef Bangladesh Limited continues the journey of pellets development with pride and perfection since 2001. In addition to the consumption in the domestic market, Eskayef is successfully exporting its pellets to Australia, Indonesia, Iran, Myanmar, UAE and Vietnam.

Since its inception on 2001, across the nation Agrovet Division has been playing an important role in the business sectors of Poultry, livestock & Aquaculture. Quality premixes along with wide range of prominent therapeutic & nutritional brands are its major strengths. Recently commissioned Injectable brands have already attained its fame for premium quality. It is also marketing imported poultry & aquaculture products from world’s top class companies. Since 2005 it has emerged as the pioneer exporter of animal health products from Bangladesh.

Eskayef believes that pharmaceutical business is built solely on the blocks of trust and it takes perseverance for a pharmaceutical business entity to earn the trust of the people. Many global best practices are being cultured in the everyday activity of Eskayef, which are contributing in a big way to shape up its future & earning people’s trust.